Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

US shutdown starts to bite – UPDATED

October 2, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, FDA, Medicare, Obama, Obamacare

Twenty-four hours into the US government’s shutdown, the impact on pharma of the freezing of federal government activity remains hard …
News

Calls to end UK anti-vaccine magazine

October 2, 2013 Medical Communications, Sales and Marketing Cancer, Vaccine, sense about science

British retailers like Tesco and WH Smiths are being urged to drop an anti-vaccine magazine as it could be dangerous …
News

Hunt: ‘We will never cover up’

October 2, 2013 Sales and Marketing CQC, Cameron, Hunt, NHS

In a speech which mixed the personal and the political at the Conservative Party conference in Manchester yesterday, health secretary …
News

TKL Research hires VP of regulatory affairs

October 2, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roxanne Tavakkol, TKL research

Clinical research organisation TKL Research has appointed Roxanne Tavakkol to the position of vice president, regulatory and scientific services. Tavakkol …
Appointment

Perjeta becomes first approved drug for early breast cancer

October 1, 2013 Sales and Marketing FDA, Herceptin, Perjeta, Roche

Roche’s Perjeta has become the first preoperative breast cancer drug to be authorised by the FDA after it was granted …
News

MHRA: Cervarix ‘in clear’

October 1, 2013 Sales and Marketing GSK, Gardasil, MHRA, ceravix

Cervarix, a key drug in the UK government’s human papillomavirus (HPV) vaccination programme, has been cleared of any involvement in …
News

Merck makes big changes at the top

October 1, 2013 Medical Communications, Sales and Marketing Merck, Merck Serono

Merck has reshuffled its leadership as Belén Garijo is appointed to be its new president and chief executive of Merck …
News

Aspen buys GSK plant and thrombosis drugs for $1.1 billion

October 1, 2013 Manufacturing and Production, Sales and Marketing GSK, aspen

South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …
News

Cancer survival rates linked to government spending in EU

October 1, 2013 Research and Development, Sales and Marketing CDF, Cancer, EU, NICE

The bigger an EU country’s healthcare budget, the greater its cancer patients’ prospects of survival, according to new research released …
News

Boehringer cancer drug impresses

October 1, 2013 Research and Development, Sales and Marketing Boehringer, NSCLC, nintedanib

Boehringer Ingelheim has shown off its impressive oncology treatment nintedanib at the European Cancer Congress (ECC) in Amsterdam. The oral triple …
News

Eisai restates Halaven’s challenge to Roche’s Xeloda

September 30, 2013 Research and Development, Sales and Marketing ECC, Halaven, Roche, Xeloda

Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …
News

Oliver Brandicourt joins Bayer from Pfizer

September 30, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Oliver Brandicourt, Pfizer

Bayer Healthcare has appointed Pfizer’s executive Olivier Brandicourt to head up its healthcare division. Taking over from interim head Wolfgang …
Appointment

Sanofi starts work on ‘largest African facility’

September 30, 2013 Manufacturing and Production, Sales and Marketing Africa, Sanofi, algeria

Sanofi has started construction of a €70 million manufacturing facility in Algeria that will be the company’s largest site in …
News

Roche cancer treatment shows promise

September 30, 2013 Sales and Marketing MPDL3280A, Merck Serono, NSCLC, Roche

An early-stage oncology treatment has shown encouraging results in smokers with lung cancer, Roche has said in a presentation at …
News

GSK in Barclays deal

September 30, 2013 Sales and Marketing GSK, Zambia, barclays, csr

GlaxoSmithKline has signed a deal with banking giant Barclays in a bid to improve private sector health in Zambia, thus …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026